Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia.

Trial Profile

Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 15 Mar 2012 This trial has been discontinued in Portugal.
    • 15 Mar 2012 Additional location (Portugal) added as reported by European Clinical Trials Database.
    • 15 Mar 2012 Actual end date changed from Dec 2009 to Apr 2010 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top